Stay updated on XMT-1660 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor update to the page version rather than study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, replacing the previous version. This indicates a minor maintenance/upgrade with no evident changes to user-facing content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's revision tag has been updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe study title and drug name were updated from XMT-1660 to Emi-Le (Emiltatug Ledadotin), with new sponsor and contact details, expanded locations, and revised study dates and design (Phase 1/2 EMBLEM-1). The record now presents Emi-Le as the investigational drug and reflects the current recruitment status and endpoints.SummaryDifference2%

- Check83 days agoChange DetectedNew enrollment and help navigation items were added to the study details page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. A formatting change in the Intervention/Treatment label replaces the previous Intervention / Treatment and the documentation revision note advanced from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check91 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov entry was published.SummaryDifference0.0%

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.